Description

OFOXO-OZ TAB

Indications

OFOXO-OZ TAB is a combination medication primarily indicated for the treatment of various bacterial infections. It is commonly prescribed for conditions such as respiratory tract infections, urinary tract infections, and skin infections. The formulation is particularly effective against infections caused by susceptible strains of bacteria, making it a valuable option in the management of these conditions.

Mechanism of Action

OFOXO-OZ TAB combines two active ingredients: Ofloxacin and Ornidazole. Ofloxacin is a fluoroquinolone antibiotic that works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication and repair. This inhibition leads to the death of the bacteria. Ornidazole, on the other hand, is an antiprotozoal and antibacterial agent that disrupts the DNA synthesis of anaerobic bacteria and protozoa, enhancing the overall efficacy of the treatment. Together, these components provide a broad-spectrum antimicrobial effect, targeting both aerobic and anaerobic organisms.

Pharmacological Properties

The pharmacokinetics of OFOXO-OZ TAB reveal that Ofloxacin is well-absorbed from the gastrointestinal tract, achieving peak plasma concentrations within 1-2 hours after oral administration. It has a bioavailability of approximately 96%. The drug is widely distributed in body tissues and fluids, including the lungs, liver, and kidneys, and is primarily excreted via the kidneys. Ornidazole also exhibits good absorption and bioavailability, with peak plasma levels reached within 1-2 hours. It is metabolized in the liver and excreted in urine and feces. The combination of these two agents allows for effective treatment of polymicrobial infections.

Contraindications

OFOXO-OZ TAB is contraindicated in patients with a known hypersensitivity to Ofloxacin, Ornidazole, or any other components of the formulation. It should also be avoided in individuals with a history of tendon disorders related to fluoroquinolone use, as these medications can increase the risk of tendon rupture. Additionally, it is not recommended for use in pregnant or breastfeeding women unless clearly necessary, as the safety of these agents in such populations has not been established.

Side Effects

Common side effects associated with OFOXO-OZ TAB may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. Central nervous system effects such as headache, dizziness, and insomnia may also occur. Rare but serious side effects include tendonitis, tendon rupture, and hypersensitivity reactions, including anaphylaxis. Patients should be advised to report any unusual or severe side effects to their healthcare provider promptly.

Dosage and Administration

The recommended dosage of OFOXO-OZ TAB varies depending on the type and severity of the infection being treated. Generally, the standard adult dosage is one tablet taken orally twice daily, preferably after meals to minimize gastrointestinal irritation. The duration of therapy typically ranges from 5 to 14 days, depending on the clinical response and the specific infection being treated. It is essential for patients to complete the full course of therapy as prescribed, even if symptoms improve before the medication is finished.

Interactions

OFOXO-OZ TAB may interact with several other medications, which can affect its efficacy or increase the risk of adverse effects. Notable interactions include antacids containing magnesium or aluminum, which can reduce the absorption of Ofloxacin. Concurrent use of NSAIDs may increase the risk of CNS stimulation and seizures. Additionally, caution should be exercised when using anticoagulants, as Ofloxacin may enhance their effects, leading to an increased risk of bleeding. It is crucial for patients to inform their healthcare provider of all medications they are taking to avoid potential interactions.

Precautions

Patients should be advised to use OFOXO-OZ TAB with caution if they have a history of renal impairment, as dosage adjustments may be necessary. It is also important to monitor patients for signs of peripheral neuropathy, as fluoroquinolones can cause nerve damage. Patients with a history of seizures or other CNS disorders should be closely monitored during treatment. Additionally, it is advisable to avoid excessive sun exposure or tanning beds while taking this medication, as Ofloxacin can increase photosensitivity.

Clinical Studies

Several clinical studies have evaluated the efficacy and safety of OFOXO-OZ TAB in the treatment of various infections. In a randomized controlled trial involving patients with complicated urinary tract infections, the combination of Ofloxacin and Ornidazole demonstrated superior efficacy compared to monotherapy with Ofloxacin alone. Another study highlighted the effectiveness of OFOXO-OZ TAB in treating anaerobic infections, showing a significant reduction in infection rates and improved patient outcomes. These studies support the use of this combination therapy as a valuable option in managing polymicrobial infections.

Conclusion

OFOXO-OZ TAB is a potent combination medication that effectively treats a range of bacterial infections. Its dual action against both aerobic and anaerobic bacteria makes it a versatile choice for healthcare providers. However, it is essential for patients to be aware of potential side effects, drug interactions, and the importance of adhering to prescribed dosages. As with any medication, responsible use under the guidance of a healthcare professional is crucial to ensure optimal therapeutic outcomes.